Efficacy and safety of AbGn-168H in patients with moderate to severe active ulcerative
Is AbGn-168H a safe and effective treatment for moderate to severe ulcerative colitis?
Basic Study Information
Purpose:Location: University of Rochester Medical Center
The purpose of this study is to evaluate the safety and effectiveness of the drug
AbGn-168H in patients who have moderate to severe Ulcerative Colitis. The study will
test use of the drug AbGn-168H for 26 weeks. To determine if the drug is safe and
effective, patients will come to the clinic regularly to meet with the study team,
complete questionnaires, and have blood work completed.
Study Reference #: 72260
Lead Researcher (Principal Investigator)
Lead Researcher: Lawrence Saubermann
Study Contact InformationStudy Coordinator: Cindy Doane
Phone: (585) 276-6019
Additional Study Details
Learn More About These Conditions
More information about Colitis, Ulcerative
Trial Not Found
The study you are looking for is not active at this time.
Return to Search